AI help for early esophageal cancer depth check during endoscopy
Part of Cancer, Digestive system clinical trials.
This trial tests if artificial intelligence can help doctors more accurately determine how deep early esophageal cancer goes during an endoscopic ultrasound. It may lead to better treatment decisions for people with early signs of esophageal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have one of these conditions: esophageal ulcer, low- or high-grade abnormal cell changes, esophageal squamous cell cancer, white patches on the esophageal lining, or a noncancerous growth (polyp) in the esophagus.
- You need to have records from a previous endoscopy with detailed pathology results.
- You must agree to take part in the study.
- You cannot have had surgery for esophageal cancer before.
- You cannot have had radiation or chemotherapy for esophageal cancer in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence during upper endoscopy to help doctors spot signs of stomach cancer earlier. It's for people over 60 who are having an endoscopy due to high-risk symptoms.
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
This trial tests if an artificial intelligence program can help doctors better detect certain pre-cancerous changes in the stomach lining during an advanced endoscopy procedure. It may benefit people at average risk who are already scheduled for this type of exam.
This trial tests whether a computer program can help doctors find and stop bleeding faster during a procedure called endoscopic submucosal dissection (ESD), which removes early-stage tumors from the digestive tract. If you are having ESD, this AI tool might make the procedure safer and quicker.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This trial tests an AI system to help guide doctors during a minimally invasive procedure to remove early-stage lesions in the esophagus, stomach, or colon. If you're scheduled for this surgery, the AI may help make it safer and more precise.
Hear when a new Esophageal Cancer Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.